Kato, T., Kagawa, Y., Kuboki, Y., Gamoh, M., Komatsu, Y., Yasui, H., . . . Yamaguchi, K. (2021). Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study. Int J Clin Oncol.
Styl ChicagoKato, Takeshi, et al. "Safety and Efficacy of Panitumumab in Combination With Trifluridine/tipiracil for Pre-treated Patients With Unresectable, Metastatic Colorectal Cancer With Wild-type RAS: The Phase 1/2 APOLLON Study." Int J Clin Oncol 2021.
Citace podle MLAKato, Takeshi, et al. "Safety and Efficacy of Panitumumab in Combination With Trifluridine/tipiracil for Pre-treated Patients With Unresectable, Metastatic Colorectal Cancer With Wild-type RAS: The Phase 1/2 APOLLON Study." Int J Clin Oncol 2021.